Two major studies converged on the adult thymus as a clinically relevant organ beyond development. Mass General Brigham researchers used AI on 27,000 CT scans and medical records to link thymic health with lower rates of cardiovascular disease, cancer, and all‑cause mortality. A separate multi‑cohort analysis found that patients with healthier thymuses had improved responses to cancer immunotherapy. Authors emphasized that thymic involution varies widely across adults and that thymic function correlates with T‑cell output and systemic immune competence. The findings were published in Nature and include real‑world data linking radiographic thymic measures to clinical endpoints and immunotherapy success rates. The work suggests potential stratification biomarkers for immunotherapy and raises interest in interventions to preserve or restore thymic function as part of precision oncology and healthy‑aging strategies.